Eintrag weiter verarbeiten
Biomarkers in Cardiovascular Disease
Gespeichert in:
| Personen und Körperschaften: | , |
|---|---|
| Titel: | Biomarkers in Cardiovascular Disease/ edited by Vinood B. Patel, Victor R. Preedy |
| Format: | E-Book |
| Sprache: | Englisch |
| veröffentlicht: |
Dordrecht
Springer
2019
|
| Gesamtaufnahme: |
Biomarkers in Disease: Methods, Discoveries and Applications Springer eBook Collection Springer Nature Living Reference |
| Schlagwörter: | |
| Quelle: | Verbunddaten SWB |
| LEADER | 04381cam a22007812 4500 | ||
|---|---|---|---|
| 001 | 0-166865511X | ||
| 003 | DE-627 | ||
| 005 | 20230309091545.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190701s2019 ne |||||o 00| ||eng c | ||
| 020 | |a 9789400777415 |9 978-94-007-7741-5 | ||
| 024 | 7 | |a 10.1007/978-94-007-7741-5 |2 doi | |
| 035 | |a (DE-627)166865511X | ||
| 035 | |a (DE-599)KEP044404867 | ||
| 035 | |a (DE-He213)978-94-007-7741-5 | ||
| 035 | |a (EBP)044404867 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-NL | ||
| 050 | 0 | |a RC261-271 | |
| 060 | 0 | |a WG 141 | |
| 082 | 0 | |a 614.5999 |2 23 | |
| 084 | |a MJCL |2 thema | ||
| 084 | |a MJCL |2 bicssc | ||
| 084 | |a MED062000 |2 bisacsh | ||
| 245 | 1 | 0 | |a Biomarkers in Cardiovascular Disease |c edited by Vinood B. Patel, Victor R. Preedy |
| 264 | 1 | |a Dordrecht |b Springer |c 2019 | |
| 300 | |a 1 Online-Ressource (Approx. 800 p. 50 illus) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Biomarkers in Disease: Methods, Discoveries and Applications | |
| 490 | 0 | |a Springer eBook Collection | |
| 490 | 0 | |a Springer Nature Living Reference |a Biomedical and Life Sciences | |
| 520 | |a Cardiolog -- Addictions -- Immunology -- Birth Defects -- Genetics | ||
| 520 | |a In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry. Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies. New analytical methods that have been used to identify markers of disease and is suggested that there may be as many as 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of markers. There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues. Hence the formulation of Biomarkers in Disease. The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics, and so on. The chapters are written by national or international experts and specialists | ||
| 650 | 0 | |a Toxicology | |
| 650 | 0 | |a Oncology . | |
| 650 | 0 | |a Oncology | |
| 650 | 0 | |a Cancer research. | |
| 650 | 0 | |a Oncology | |
| 650 | 0 | |a Cancer Research | |
| 650 | 0 | |a Pharmacology. | |
| 650 | 2 | |a Cardiovascular Diseases |x diagnosis | |
| 650 | 2 | |a Cardiovascular Diseases |x prevention & control | |
| 650 | 2 | |a Biomarkers | |
| 650 | 2 | |a Risk Factors | |
| 700 | 1 | |a Patel, Vinood B. |e HerausgeberIn |4 edt | |
| 700 | 1 | |a Preedy, Victor R. |e HerausgeberIn |4 edt | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-94-007-7741-5 |m X:SPRINGER |x Resolving-System |z lizenzpflichtig |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-94-007-7741-5 |m X:SPRINGER |x Resolving-System |z lizenzpflichtig |
| 912 | |a GBV-2-SprRefEng | ||
| 912 | |a ZDB-2-SBL |b 2019 | ||
| 912 | |a ZDB-2-SBL |b 2020 | ||
| 912 | |a ZDB-2-SEB | ||
| 912 | |a ZDB-2-SEB |b 2020 | ||
| 912 | |a ZDB-2-SXRB |b 2020 | ||
| 912 | |a ZDB-2-SLR |b 2020 | ||
| 951 | |a BO | ||
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-94-007-7741-5 |9 DE-14 |
| 852 | |a DE-14 |x epn:3491099986 |z 2019-07-04T17:41:01Z | ||
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-94-007-7741-5 |9 DE-Ch1 |
| 852 | |a DE-Ch1 |x epn:380684058X |z 2020-11-19T01:35:21Z | ||
| 975 | |o Springer E-Book | ||
| 975 | |k Elektronischer Volltext - Campuslizenz | ||
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-94-007-7741-5 |9 DE-Zwi2 |
| 852 | |a DE-Zwi2 |x epn:3604096359 |z 2020-03-05T15:33:08Z | ||
| 980 | |a 166865511X |b 0 |k 166865511X | ||
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Biomarkers+in+Cardiovascular+Disease&rft.date=2019&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle=Biomarkers+in+Cardiovascular+Disease&rft.series=Biomarkers+in+Disease%3A+Methods%2C+Discoveries+and+Applications&rft.au=&rft.pub=Springer&rft.edition=&rft.isbn=9400777418 |
|---|
| _version_ | 1792254569718218752 |
|---|---|
| access_facet | Electronic Resources |
| author2 | Patel, Vinood B., Preedy, Victor R. |
| author2_role | edt, edt |
| author2_variant | v b p vb vbp, v r p vr vrp |
| author_facet | Patel, Vinood B., Preedy, Victor R. |
| callnumber-first | R - Medicine |
| callnumber-label | RC261-271 |
| callnumber-raw | RC261-271 |
| callnumber-search | RC261-271 |
| callnumber-sort | RC 3261 3271 |
| callnumber-subject | RC - Internal Medicine |
| collection | GBV-2-SprRefEng, ZDB-2-SBL, ZDB-2-SEB, ZDB-2-SXRB, ZDB-2-SLR |
| contents | Cardiolog -- Addictions -- Immunology -- Birth Defects -- Genetics, In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry. Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies. New analytical methods that have been used to identify markers of disease and is suggested that there may be as many as 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of markers. There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues. Hence the formulation of Biomarkers in Disease. The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics, and so on. The chapters are written by national or international experts and specialists |
| ctrlnum | (DE-627)166865511X, (DE-599)KEP044404867, (DE-He213)978-94-007-7741-5, (EBP)044404867 |
| dech1_date | 2020-11-19T01:35:21Z |
| dewey-full | 614.5999 |
| dewey-hundreds | 600 - Technology |
| dewey-ones | 614 - Incidence & prevention of disease |
| dewey-raw | 614.5999 |
| dewey-search | 614.5999 |
| dewey-sort | 3614.5999 |
| dewey-tens | 610 - Medicine & health |
| doi_str_mv | 10.1007/978-94-007-7741-5 |
| facet_912a | GBV-2-SprRefEng, ZDB-2-SBL, ZDB-2-SEB, ZDB-2-SXRB, ZDB-2-SLR |
| facet_avail | Online |
| finc_class_facet | Technik, Medizin |
| fincclass_txtF_mv | medicine |
| format | eBook |
| format_access_txtF_mv | Book, E-Book |
| format_de105 | Ebook |
| format_de14 | Book, E-Book |
| format_de15 | Book, E-Book |
| format_del152 | Buch |
| format_detail_txtF_mv | text-online-monograph-independent |
| format_dezi4 | e-Book |
| format_finc | Book, E-Book |
| format_legacy | ElectronicBook |
| format_legacy_nrw | Book, E-Book |
| format_nrw | Book, E-Book |
| format_strict_txtF_mv | E-Book |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | 0-166865511X |
| illustrated | Not Illustrated |
| imprint | Dordrecht, Springer, 2019 |
| imprint_str_mv | Dordrecht: Springer, 2019 |
| institution | DE-14, DE-Zwi2, DE-Ch1 |
| is_hierarchy_id | |
| is_hierarchy_title | |
| isbn | 9789400777415 |
| kxp_id_str | 166865511X |
| language | English |
| last_indexed | 2024-02-29T17:19:11.437Z |
| local_heading_facet_dezwi2 | Toxicology, Oncology ., Oncology, Cancer research., Oncology , Cancer Research, Pharmacology., Cardiovascular Diseases, Biomarkers, Risk Factors, diagnosis, prevention & control |
| marc024a_ct_mv | 10.1007/978-94-007-7741-5 |
| match_str | patel2019biomarkersincardiovasculardisease |
| mega_collection | Verbunddaten SWB |
| physical | 1 Online-Ressource (Approx. 800 p. 50 illus) |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publishPlace | Dordrecht |
| publisher | Springer |
| record_format | marcfinc |
| record_id | 166865511X |
| recordtype | marcfinc |
| rvk_facet | No subject assigned |
| series2 | Biomarkers in Disease: Methods, Discoveries and Applications, Springer eBook Collection, Springer Nature Living Reference ; Biomedical and Life Sciences |
| source_id | 0 |
| spelling | Biomarkers in Cardiovascular Disease edited by Vinood B. Patel, Victor R. Preedy, Dordrecht Springer 2019, 1 Online-Ressource (Approx. 800 p. 50 illus), Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Biomarkers in Disease: Methods, Discoveries and Applications, Springer eBook Collection, Springer Nature Living Reference Biomedical and Life Sciences, Cardiolog -- Addictions -- Immunology -- Birth Defects -- Genetics, In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry. Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies. New analytical methods that have been used to identify markers of disease and is suggested that there may be as many as 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of markers. There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues. Hence the formulation of Biomarkers in Disease. The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics, and so on. The chapters are written by national or international experts and specialists, Toxicology, Oncology ., Oncology, Cancer research., Oncology , Cancer Research, Pharmacology., Cardiovascular Diseases diagnosis, Cardiovascular Diseases prevention & control, Biomarkers, Risk Factors, Patel, Vinood B. HerausgeberIn edt, Preedy, Victor R. HerausgeberIn edt, https://doi.org/10.1007/978-94-007-7741-5 X:SPRINGER Resolving-System lizenzpflichtig, https://doi.org/10.1007/978-94-007-7741-5 DE-14, DE-14 epn:3491099986 2019-07-04T17:41:01Z, https://doi.org/10.1007/978-94-007-7741-5 DE-Ch1, DE-Ch1 epn:380684058X 2020-11-19T01:35:21Z, https://doi.org/10.1007/978-94-007-7741-5 DE-Zwi2, DE-Zwi2 epn:3604096359 2020-03-05T15:33:08Z |
| spellingShingle | Biomarkers in Cardiovascular Disease, Cardiolog -- Addictions -- Immunology -- Birth Defects -- Genetics, In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry. Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies. New analytical methods that have been used to identify markers of disease and is suggested that there may be as many as 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of markers. There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues. Hence the formulation of Biomarkers in Disease. The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics, and so on. The chapters are written by national or international experts and specialists, Toxicology, Oncology ., Oncology, Cancer research., Oncology , Cancer Research, Pharmacology., Cardiovascular Diseases diagnosis, Cardiovascular Diseases prevention & control, Biomarkers, Risk Factors |
| title | Biomarkers in Cardiovascular Disease |
| title_auth | Biomarkers in Cardiovascular Disease |
| title_full | Biomarkers in Cardiovascular Disease edited by Vinood B. Patel, Victor R. Preedy |
| title_fullStr | Biomarkers in Cardiovascular Disease edited by Vinood B. Patel, Victor R. Preedy |
| title_full_unstemmed | Biomarkers in Cardiovascular Disease edited by Vinood B. Patel, Victor R. Preedy |
| title_short | Biomarkers in Cardiovascular Disease |
| title_sort | biomarkers in cardiovascular disease |
| title_unstemmed | Biomarkers in Cardiovascular Disease |
| topic | Toxicology, Oncology ., Oncology, Cancer research., Oncology , Cancer Research, Pharmacology., Cardiovascular Diseases diagnosis, Cardiovascular Diseases prevention & control, Biomarkers, Risk Factors |
| topic_facet | Toxicology, Oncology ., Oncology, Cancer research., Oncology , Cancer Research, Pharmacology., Cardiovascular Diseases, Biomarkers, Risk Factors, diagnosis, prevention & control |
| url | https://doi.org/10.1007/978-94-007-7741-5 |